ValuentumAd

Official PayPal Seal

Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Sep 12, 2016
The Quiet Analyst Speaks
Image: Mailslot for Cantor Fitzgerald, on the top floors of the WTC. The mailslot was located in a post office near the WTC site. The mailslots are with the Smithsonian Institution. Travis Wise. Let's get caught up...
Aug 10, 2016
Oncology News a Key Driver of Big Pharma
Image Source: Images Money. Oncology product portfolios and pipelines have been key factors in the big pharma industry as of late.
Jul 27, 2016
Gilead’s Harvoni Sales Dip Considerably in the US
Image Source: Gilead. The bull case for owning Gilead has become bleak.
Jul 19, 2016
The J&J-Gilead Trade-off Update
Some of our members were not happy when we swapped out Gilead and replaced it with Johnson & Johnson in the portfolio of the Best Ideas Newsletter. How have things progressed since that trade late January?
Jun 15, 2016
5 Years Strong!
Image Source: Andy Maguire. So much to say... let's talk.
May 3, 2016
Dividend Increases/Decreases for the Week Ending April 29
Let's take a look at companies raising/lowering their dividends this week.
May 3, 2016
A Letter from the President
“We’re Valuentum, not value – and that’s all the difference in the world.” – Brian Nelson, CFA
May 2, 2016
Gilead: What's Your Long Term Thesis?
Image Source: Gilead. We’re starting to see some even bigger risks at Gilead – long-term ones.
Apr 29, 2016
Gilead Disappoints, Harvoni Sales Drop 16%
Image Source: Gilead. In January 2016, we had removed Gilead from the Best Ideas Newsletter portfolio, and we added steady-eddy dividend growth giant Johnson & Johnson in its place. We were starting to think we might have made a mistake … until today.
Apr 21, 2016
The Market – On Its Head
Let’s discuss what’s been working and what’s not been working in today’s market.


Latest News and Media

The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.